Kapila K. Anand - 05 Jun 2026 Form 4 Insider Report for OMEGA HEALTHCARE INVESTORS INC (OHI)

Reporting relationship: Director
Issuer ticker: OHI
Reported as of: 05 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2026, 16:15:29 UTC
Prior SEC filing: 26 May 2026
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Meghan C. Lyons, Attorney-in-Fact

Key filing fact

Kapila K. Anand filed Form 4 for OMEGA HEALTHCARE INVESTORS INC (OHI) on 09 Jun 2026.

Key facts

This page summarizes Kapila K. Anand's Form 4 filing for OMEGA HEALTHCARE INVESTORS INC (OHI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2026, 16:15.

Change

Previous filing in this sequence was filed on 26 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001679166 Primary reporting owner

Anand Kapila K

Relationship: Director
Address: 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY
Signature: /s/ Meghan C. Lyons, Attorney-in-Fact
Signature date: 09 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OHI transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares: +6,205
Change %: +16%
Price: $0.000000^*
Shares after: 44,992
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,205
Exercise price
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

Footnote F2

These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").

Footnote F3

These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

Footnote F4

These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.